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through PMAIP1-USP9X-MCL1 axis in human
bladder cancer cells
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BIX-01294, an euchromatic histone-lysine N-methyltransferase 2 (EHMT2) inhibitor, has been reported to induce
apoptosis in human neuroblastoma cells and inhibit the proliferation of bladder cancer cells. However, the definite
mechanism of the apoptosis mediated by BIX-01294 in bladder cancer cells remains unclear. In the present study,
we found that BIX-01294 induced caspase-dependent apoptosis in human bladder cancer cells. Moreover, our data
show BIX-01294 stimulates endoplasmic reticulum stress (ER stress) and up-regulated expression of PMAIP1 through
DDIT3 up-regulation. Furthermore, down-regulation of the deubiquitinase USP9X by BIX-01294 results in downstream
reduction of MCL1 expression, leading to apoptosis eventually. Thus, our findings demonstrate PMAIP1-USP9X-MCL1
axis may contribute to BIX-01294-induced apoptosis in human bladder cancer cells.
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EHMT2, also known as G9a, is an important enzyme for
histone H3 dimethylation at lysine-9 [1,2]. EHMT2 is
overexpressed in breast, prostate, colon, bladder, ovarian,
melanoma, lung, and liver cancers [3-5]. Recent research
shows that enhanced expression of EHMT2 is involved
in the proliferation of cancer cells [6]. BIX-01294, a
diazepin-quinazolinamine derivative, is a specific in-
hibitor of EHMT2 by reducing the H3K9Me2 level [7].
Furthermore, BIX-01294 is the first small compound
that can replace Oct4 to induce neural stem cells to be
reprogrammed into iPSCs [8]. Moreover, BIX-01294
can induce apoptosis in human neuroblastoma cells by
raising CASP8 and CASP3 activity [9]. BIX-01294 also
can decrease the proliferating activity of bladder cancer
cells [6]. It was reported that knockdown of EHMT2 by
siRNA [3,4,10,11] or treatment with BIX-01294 [10,12,13]
inhibited growth of bladder, lung, prostate, and breast
cancer cells.* Correspondence: xgliu@sdu.edu.cn
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unless otherwise stated.A variety of detrimental stimuli, such as ultraviolet
light, hypoxia, oxidative stress, can affect the function of
ER (endoplasmic reticulum), leading to accumulation of
unfolded or misfolded protein in ER and activation of
ER stress response [14-18]. A large number of unfolded
or misfolded proteins can bind to HSPA5, and then acti-
vate three pathways through PERK, ERN1 and ATF6.
The long-term, severe ER stress will ultimately induce
cell apoptosis [19]. DDIT3 is a transcriptional factor and
the downstream member of ER stress pathways [20,21].
Recent studies have shown that numerous drugs, such
as lonafarnib, MG132, CDDO-Me and pemetrexed up-
regulate DDIT3 expression via p-EIF2S1-ATF4 axis and
accordingly enhance apoptosis through induction of
DR5 or Bim etc. [22-24].
Mitochondrion is at the center of intrinsic apoptotic
pathway. Under the regulation of BCL-2 family, Cyt c, a
component of mitochondrial electron transport chain,
can be released into cytoplasm through a hole related to
the oligomerization of BAX/BAK and VDAC (voltage-
dependent anion channel). The Cyt c in cytoplasm can
combine with APAF1 and induce cell apoptosis [25].
MCL1 drives its pro-survival function by combining with
BAX/BAK and inhibiting the oligomerization. PMAIP1
belongs to the pro-apoptotic BH3-only family and hass is an Open Access article distributed under the terms of the Creative
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through binding to them [26]. Several BH3-only family
proteins, including PMAIP1, can be activated by DDIT3
[27]. Notably, PMAIP1 can control the stability of MCL1
through regulating its polyubiquitination which E3 ligase
HUWE1 or FBW7 are involved in [28]. Ubiquitin specific
peptidase 9x (USP9X), a deubiquitinase belonging to USP
family, can stabilize MCL1 through removing the polyubi-
quitin chains linked by Lys-48 which is the essential sign
in proteasomal degradation process, and it is overex-
pressed in several kinds of cancer cells [29]. Moreover,
over-expression of PMAIP1 may trigger a decrease in the
USP9X/MCL1 interaction [28]. Recent studies also show
that high level of PMAIP1 likely reduces the availability of
USP9X to MCL1, thereby promoting the ubiquitination
and degradation of MCL1, leading to the apoptosis of neo-
plastic cells [30].
However, the specific mechanism of apoptosis mediated
by BIX-01294 in bladder cancer cells remains unknown.
The goal of our research was to investigate which pathway
BIX-01294 follows to induce apoptosis in human bladder
cancer cells and which proteins play important roles in
this process. In our research, BIX-01294 was capable of
leading to ER stress. Furthermore, DDIT3, as a down-
stream transcriptional factor in ER stress, promotes the
expression of PMAIP1 which can significantly lower
MCL1 levels. Moreover, BIX-01294 also reduces USP9X
and then affects the stability of MCL1. According to our
present study, we demonstrate that BIX-01294 causes
apoptosis in bladder cancer cells through ER stress




The powder of BIX-01294 (B9311) trihydrochloride
and EHMT2 (G6919) antibody were purchased from
Sigma-Aldrich (City of Saint Louis, Missouri, US). CASP3
(IMG-145) antibody was purchased from Imgenex.
USP9X (5751), DDIT3 (2895), CASP8 (9746), CASP9
(9502), PARP1 (9542), HSPA5 (3183) and ERN1 (3294)
antibodies were purchased from Cell Signaling Technol-
ogy (Boston, Massachusetts, US). ATF4 (SC-200) and
MCL1 (SC-12756) antibodies were obtained from Santa
Cruz Biotechnology (Santa Cruz, California, US). PMAIP1
(OP180) antibody was purchased from Calbiochem (San
Diego, California, US).
Cell lines and cell culture
The human bladder cell lines T24 and 5637 were obtained
from the Cell Bank of Shanghai Institute of Biochemistry
and Cell Biology, Chinese Academy of Sciences (Shanghai,
China). T24 and 5637 were grown in monolayer culture at
37°C in a humidified atmosphere consisting of 5% CO2and 95% air. The T24 cell line was cultured in McCoy's
5A Modified Media (Sigma-Aldrich) supplemented with
5% (v/v) FBS (SAFC®Global) and the 5637 cell line was
cultured in RPMI 1640 (Sigma-Aldrich) supplemented
with 5% (v/v) FBS.
Western blot analysis
Preparation of whole cell protein lysates and the
procedures for the Western blot analysis were already
described [31].
siRNA transfections
All the siRNAs were synthesized by GenePharma. The
small interfering RNA (siRNA) duplexes for control, DDIT3
siRNA duplexes target the sequence 5'-GCCTGGTATGAG
GACCTGC-3' [32]. EHMT2 siRNA duplexes target the
sequence 5′-GCATTTCCGCATGAGTGAT-3′. PMAIP1
siRNA duplexes target the sequence 5′-GGAAGUCGAG
UGUGCUACU-3′, USP9X siRNA duplexes target the se-
quence 5′-CAATCAAGTTCAATGATTA-3′, The trans-
fection of siRNA was conducted with X-tremeGENE
siRNA Transfection Reagent (Roche) following the
instructions.
Cell survival assay
On the first day, cells were seeded in 96 well plates.
Twenty-four hours later, BIX-01294 was added at the
indicated concentrations in each well. After treatment by
BIX-01294 for another 24 h, we used 10% TCA to
immobilize the cells and then evaluated the living cell
numbers using the sulforhodamine B assay as previously
described [33].
Apoptosis assays
Apoptosis was detected by the Annexin V-FITC Apoptosis
Detection Kit (BIOBOX) following the manufacturer’s
protocol. Activation of the caspase family was evaluated by
western blot.
Construction of the plasmid
MCL1 gene was amplified from A549 cells cDNA with
PCR technique using the primers described as below:
5′-CGGATCCGCCGCCACCATGTGTTTGGCCTCAA
AAGAAACG-3′ (sense); 5′-CGGGCCCCTATCTTATT
AGATATGCCAAAC-3′ (antisense). This resultant con-
struct was named pcDNA3.1-MCL1 after MCL1 gene was
cloned into pcDNA3.1 (+) vector by using Bam HI and
Apa I restriction sites [30].
Plasmid transient transfections
On the first day, T24 and 5637 cells were seeded into 6-
well plates. On the second day, cells were transfected with
pcDNA3.1 and pcDNA3.1-MCL1 using X-tremeGENE
HP DNA Transfection Reagent (Roche). On the third day,
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for 24 hours. On the fourth day, the cells were harvested
for western blot.
Results
BIX-01294 induces caspase-dependent apoptosis in human
bladder cancer cell lines
We examined BIX-01294’s biological effect in cell lines
T24 and 5637 to figure out whether this agent induced
caspase-dependent apoptosis in human bladder cancer
cells. Cell survival rate was determined by SRB assays
(Figure 1A) after the cells were treated with 1.25, 2.5, 5,
10 or 20 μmol/l of BIX-01294 for 24 hours. The data
show that BIX-01294 inhibited the cell proliferation in a
concentration-dependent manner in T24 and 5637 cells.
Western blot analysis demonstrates that BIX-01294 (0, 5,
10 μmol/l) significantly activated CASP8, CASP9, CASP3
and cleaved the substrate of CASP3, PARP1 in bladder
cancer cells treated for 24 hours (Figure 1B). At the same
concentration, it is observed that the cleavage of caspases
and PARP1 increased gradually over time (Figure 1C). To
characterize whether the apoptosis induced by BIX-01294
is related to EHMT2, we treated cells with BIX-01294Figure 1 BIX-01294 induces apoptosis in human bladder cancer cells.
day and treated with 1.25, 2.5, 5, 10 and 20 μmol/l of BIX-01294 on the sec
using SRB assay for calculation of cell survival. Points: mean of four replicat
indicated concentrations of BIX-01294 for 24 hours and harvested for West
antibodies against CASP8, CASP9, CASP3, PARP1 and ACTB. (C) T24 and 563
time. Both attached and suspended cells were harvested for Western blot a
against CASP8, CASP3, PARP1 and ACTB. CF: cleaved form. (D) Forty-eight h
treated with 10 μmol/l of BIX-01294. Whole-cell protein lysates were harves
analyzed by using antibodies against EHMT2, CASP8, CASP9, CASP3, PARP1after the cells were transfected with EHMT2 siRNA. As
shown in Figure 1D, the cleaved caspases and PARP1
increased apparently upon the inhibition of EHMT2 ex-
pression. In summary, BIX-01294, as a specific inhibitor
of EHMT2, induces caspase-dependent apoptosis in a
dose- and time-dependent manner in human bladder can-
cer cells.
BIX-01294 induces up-regulation of PMAIP1 and
down-regulation of MCL1 in human bladder cancer cells
PMAIP1, a member of pro-apoptotic BH3-only protein
family, is located at the outer mitochondrial membrane
and plays critical role in the apoptosis induced by many
chemotherapeutic agents in cancer cells [34]. As a mem-
ber of anti-apoptotic proteins in BCL-2 family, MCL1 is
overexpressed in many kinds of human cancers. In our
model, BIX-01294 increased the expression of PMAIP1
and decreased the level of MCL1 in a concentration-
and time-dependent manner in human bladder cells
(Figure 2A and 2B). Moreover, PMAIP1 knockdown with
siRNA dramatically eased the alteration of USP9X and
rescued the changes of MCL1, CASP9, CASP3 and
PARP1 (Figure 2C). The fraction of apoptotic cells in(A) The indicated cell lines were seeded in 96-well plates on the first
ond day. After treatment for 24 hours, live cell number was estimated
e determinations; bars: S.D. (B) T24 and 5637 cells were treated with
ern blot analysis. Levels of protein expression were analyzed by using
7 cells were treated with 10 μmol/l of BIX-01294 for various lengths of
nalysis. Levels of protein expression were analyzed by using antibodies
ours after control siRNA and EHMT2 siRNA transfection, cells were
ted for Western blot analysis. Levels of protein expression were
and ACTB.
Figure 2 BIX-01294 up-regulates the expression of PMAIP1 and down-regulates MCL1 in bladder cancer cells. T24 and 5637 cells were
treated with indicated concentrations of BIX-01294 for 24 hours or the cells were treated with 10 μmol/l of BIX-01294 for various lengths of time.
Both attached and suspended cells were harvested for Western blot analysis (A and B). We used control siRNA and PMAIP1 siRNA to transfect T24
(C and D) and 5637 (C and E) for 48 hours and then added BIX-01294 (10 μmol/l) into culture medium and harvested the cells for western blot
analysis by using antibodies against PMAIP1, MCL1, CASP9, CASP3, PARP1, DDIT3 and ACTB or for detection of apoptotic cells using Annexin V-FITC
staining. In D and E, the early apoptosis detected by flow cytometry is the upper one and the total apoptosis is the lower one. MCL1, CASP9, CASP3
and ACTB were detected by western blot after T24 and 5637 cells transfected with pcDNA3.1 and pcDNA3.1-MCL1 (F). Columns: mean of triplicate
treatments; bars: ± SD. The statistical differences between the two treatments were analyzed by two-sided unpaired Student’s t-tests (*p < 0.05;
**p < 0.01; *** p < 0.001).
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that in control siRNA knockdown cells after BIX-01294
exposure according to the results of flow cytometry ana-
lysis (Figure 2D and 2E). To determine the importance
of MCL1 in the process of apoptosis induced by
BIX-01294, we overexpressed MCL1 gene in human
bladder cancer cells and then treated with BIX-01294 for
24 hours. Subsequent western blot analysis showed that
overexpression of MCL1 attenuated apoptosis induced
by BIX-01294 in T24 and 5637 cells (Figure 2F). These
data suggest that PMAIP1 and MCL1 play important
role in apoptosis induced by BIX-01294 in bladder cancer
cells.BIX-01294 reduces MCL1 expression through a
USP9X-dependent mechanism
Remarkably, BIX-01294 can enhance the amount of
PMAIP1 and reduce MCL1 in bladder cancer cells
(Figure 2A and 2B). These data lead us to think
whether BIX-01294 can influence the action of USP9X
[35]. We found that BIX-01294 reduced the level of USP9X
in the dose- and time-dependent manner (Figure 3A and
3B), and MCL1 was degraded more in USP9X siRNA
knockdown cells (Figure 3C) compared with the Control
siRNA knockdown cells. In addition, BIX-01294 induced
less apoptosis in Control siRNA knockdown bladder cancer
cells than that inUSP9X siRNA knockdown cells (Figure 3D
Figure 3 BIX-01294 reduces USP9X level in the concentration- and time-dependent manner, and USP9X knockdown enhances MCL1
degradation and apoptosis. T24 and 5637 cells were treated with indicated concentrations of BIX-01294 for 24 hours or the cells were treated
with 10 μmol/l of BIX-01294 for various lengths of time. Both attached and suspended cells were harvested for Western blot analysis (A and B).
After control siRNA and USP9X siRNA transfection, cells were treated with 10 μmol/l of BIX-01294 for 24 hours. We used antibodies against USP9X,
MCL1, CASP9, CASP3, PARP1 and ACTB for western blot analysis (C) or used Annexin V-FITC Apoptosis Detection Kit for detection of apoptotic
cells in T24 (D) and 5637 (E). In D and E, the early apoptosis detected by flow cytometry is the upper one and the total apoptosis is the lower
one. Columns: mean of triplicate treatments; bars: ± SD. The statistical differences between the two treatments were analyzed by two-sided
unpaired Student’s t-tests (*p < 0.05; **p < 0.01; *** p < 0.001).
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pression of USP9X and promotes the degradation of
MCL1, which eventually leads to apoptosis in bladder
cancer cells.
DDIT3 is up-regulated by BIX-01294 and regulates the
expression of PMAIP1
It is reported that as a transcriptional factor DDIT3 can
induce apoptosis through surge of the BH3-only family
members, including PMAIP1 [36]. Accordingly, we
would like to figure out whether the expression of
PMAIP1 induced by BIX-01294 is due to DDIT3. As
we speculated, BIX-01294 was able to increase DDIT3
expression level (Figure 4A and 4B). In addition, we
pretreated T24 and 5637 cells with ER stress antagonist 4-
PBA (1 mM) for 30 minutes followed by incubation with
BIX-01294 (10 μM) for another 24 hours and then mea-
sured the expression of DDIT3, CASP9, CASP3 andACTB. The data showed that co-incubation with 4-PBA
and BIX-01294 decreased the cleaved form of CASP9
and CASP3 (Figure 4C). In order to verify whether
BIX-01294 triggers apoptosis through DDIT3, we used
siRNA technique to silence DDIT3 expression and
found that BIX-01294–induced cleavage of PARP1 was
declined significantly (Figure 4D). Besides, we observed
reduced expression of PMAIP1 and enhanced expression
of MCL1 in DDIT3 knockdown cells after exposure to
BIX-01294, suggesting that DDIT3 regulates PMAIP1 and
MCL1. Consistently, BIX-01294 induced less apoptotic
percentage in DDIT3 siRNA knockdown T24 and 5637
cells than that in Control siRNA knockdown ones ac-
cording to Annexin V-FITC staining and flow cytome-
try analysis (Figure 4E and 4F). To sum up, DDIT3, as
a downstream member of ER stress pathway, enhances
PMAIP1 expression and contributes to BIX-01294–in-
duced apoptosis.
Figure 4 BIX-01294 up-regulates the level of DDIT3, and DDIT3 knockdown suppresses the apoptosis induced by BIX-01294 in human
bladder cancer cells. T24 and 5637 cells were treated with indicated concentrations of BIX-01294 for 24 hours or the cells were treated with 10
μmol/l of BIX-01294 for various lengths of time. Both attached and suspended cells were harvested for Western blot analysis (A and B). T24 and
5637 cells were pretreated with 4-PBA-Na+ (1 mM) for 30 min and then cotreated with BIX-01294 (10 μM) for another 24 h. Levels of protein
expression were analyzed by western blot using antibodies against DDIT3, CASP9, CASP3 and ACTB (C). After control siRNA and DDIT3 siRNA
transfection, cells were treated with 10 μmol/l of BIX-01294 for 24 hours. Whole-cell protein lysates were harvested for Western blot analysis by
using antibodies against DDIT3, PARP1, PMAIP1, MCL1 and ACTB (D). T24 (E) and 5637 (F) cells were transfected with control siRNA and DDIT3
siRNA for 48 hours. After treatment with BIX-01294 (10 μmol/l) for 24 h, cells were stained with Annexin V-FITC/PI and detected by flow cytometry
analysis. In E and F, the early apoptosis detected by flow cytometry is the upper one and the total apoptosis is the lower one. Columns: mean of
triplicate treatments; bars: ± SD. The statistical differences between the two treatments were analyzed by two-sided unpaired Student’s t-tests
(*p < 0.05; **p < 0.01; *** p < 0.001).
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Since DDIT3 is a hallmark of ER stress, we wonder
whether BIX-01294 induces apoptosis through ER stress.
Moreover, DDIT3 expression strongly depends on ATF4
[37]. In our study, a number of proteins related to ER
stress, like HSPA5, ERN1 and ATF4, were increased
after treatment with BIX-01294 for 24 hours in T24 and
5637 cells (Figure 5A and 5B). In addition, we treated
T24 and 5637 cancer cells with BIX-01294 for different
lengths of time. As shown in Figure 5B, these proteins
were up-regulated by a time-dependent manner after
treated with BIX-01294. So far, we have figured out that
BIX-01294 induces the expression of DDIT3 through ac-
tivating ER stress, leading to up-regulation of PMAIP1.Discussion
To date, over-expression of EHMT2 may be a prognostic
marker for patients with melanoma and esophageal can-
cer [38,39]. In addition, EHMT2 inhibitors can prevent
the proliferation and self-renewal of AML via reducing
HoxA9-dependent transcription and also can increase
the intracellular ROS [7,40]. BIX-01294 has been demon-
strated to induce autophagy in breast and colon cancers
[7]. Earlier reports showed BIX-01294 led to apoptosis by
activating CASP8 and CASP3 in human neuroblastoma
cells and reduce the proliferation of human bladder cancer
cells. In our study, with the increase of BIX-01294 con-
centration, the cell survival rate of bladder cancer cells
T24 and 5637 reduced clearly. Moreover, by treating
Figure 5 BIX-01294 triggers ER stress response in human bladder cancer cells. (A) T24 and 5637 cells were treated with indicated
concentrations of BIX-01294 for 24 hours and harvested for Western blot analysis. Levels of protein expression were analyzed by using antibodies
against HSPA5, ERN1, ATF4 and ACTB. (B) T24 and 5637 cells were treated with 10 μmol/l of BIX-01294 for various lengths of time. Both attached
and suspended cells were harvested for Western blot analysis by using antibodies against HSPA5, ERN1, ATF4 and ACTB.
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related proteins such as CASP8, CASP9, CASP3 and
PARP1 were activated simultaneously. This means that
BIX-01294 indeed induces the apoptosis in human blad-
der cancer cells. However, the mechanisms underlying
how BIX-01294 triggers apoptosis in human bladder can-
cer cells remain unclear.
Cellular apoptosis can be induced by a long-term,
severe ER stress. Some earlier studies have found that
DDIT3, as a downstream component of ER stress, can
be activated by ATF4. We also discovered that ER stress
component, like HSPA5, ERN1, ATF4 and DDIT3,
increased when the human bladder cancer cells were
treated with BIX-01294. Moreover, the cleavage of
PARP1 were suppressed in cells transfected with
DDIT3 siRNA. This implies the BIX-01294 induces
caspase-dependent apoptosis through activating ER
stress. Notably, the expression of PMAIP1 was reduced,
while MCL1 was rescued when the cells were transfected
with DDIT3 siRNA. These results indicate that DDIT3
induces the expression of PMAIP1 which is required for
BIX-01294-induced apoptosis.
In terms of mitochondrial apoptotic pathway, PMAIP1
belongs to the BH3-only pro-apoptotic protein family
while MCL1 belongs to pro-survival BCL2 protein family.
MCL1 can be suppressed by PMAIP1 or stabilized by the
deubiquitinase USP9X [41]. We found that BIX-01294 up-
regulated the expression of PMAIP1 and down-regulated
the level of MCL1 and USP9X. In addition, in the cells
transfected with PMAIP1 siRNA, the levels of MCL1
and USP9X were augmented, while the cleaved caspases
and PARP1 were decreased. These results suggest thatBIX-01294 degrades the MCL1 through up-regulation
of PMAIP1 and reduction of USP9X, which is consistent
to our previous study that PMAIP1 upregulation reduces
the availability of USP9X to MCL1, thereby promoting its
ubiquitination and degradation, leading to the apoptosis
of neoplastic cells [35]. Since DDIT3 also modulates other
apoptotic proteins such as death receptors in the extrinsic
pathway, we cannot exclude the role of extrinsic pathway
in the apoptosis induction by BIX-01294 in bladder
cancer cells. Therefore, further investigation is re-
quired to characterize as much as details involved in
the BIX-01294-induced apoptosis.
In summary, our data demonstrate that BIX-01294
induces ER stress pathway, resulting in up-regulation of
PMAIP1 and down-regulation of USP9X and MCL1,
leading to apoptosis in bladder cancer cells. These
findings may offer important insight into the molecular
mechanism of BIX-01294, thereby accelerating its use
in clinical scenarios which may help improve bladder
cancer treatments.
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